Skip to main content
  • About Us
  • Investors
  • Careers
  • Contact Us
Choose your market:
United States
  • Global / English
  • Albania / Gjuha shqipe
  • Algeria / Français
  • Argentina / Español
  • Australia / English
  • Austria / Deutsch
  • Bahrain / English
  • Belgium / English
  • Bolivia / Español
  • Bosnia-Herzegovina / BS
  • Bosnia-Herzegovina / EN
  • Brazil / Português
  • Bulgaria / Български
  • Canada / English
  • Canada / Français
  • Chile / Español
  • China / 简体中文
  • China / English
  • Colombia / Español
  • Costa Rica / Español
  • Croatia / Hrvatski jezik
  • Croatia / English
  • Cyprus / English
  • Czech Republic / český
  • Denmark / Dansk
  • Denmark / English
  • Dominican Republic / ES
  • Ecuador / Español
  • Egypt / English
  • El Salvador / Español
  • France / Français
  • Germany / Deutsch
  • Ghana / English
  • Guatemala / Español
  • Hong Kong SAR China / English
  • Hungary / Magyar nyelv
  • India / English
  • Indonesia / English
  • Iraq / English
  • Ireland / English
  • Israel / Hebrew
  • Italy / Italiano
  • Japan / 日本語
  • Jordan / English
  • Kazakhstan / Pусский
  • Kenya / English
  • Kosovo / Gjuha shqipe
  • Kosovo / Srpski
  • Kuwait / English
  • Lebanon / English
  • Macedonia / Македонски јазик
  • Macedonia / Gjuha shqipe
  • Malaysia / English
  • México / Español
  • Montenegro / Montenegrin
  • Morocco / Français
  • Mozambique / Portuguese
  • Netherlands / Nederlands
  • Netherlands / English
  • New Zealand / English
  • Nigeria / English
  • Norway / Norsk
  • Pakistan / English
  • Panama / Español
  • Peru / Español
  • Philippines / English
  • Poland / Polski
  • Portugal / Português
  • Puerto Rico / English
  • Qatar / English
  • Romania / Română
  • Romania / English
  • Russia / Pусский
  • Saudi Arabia / English
  • Serbia / Srpski
  • Singapore / English
  • Slovakia / Slovenský
  • Slovenia / Slovenščina
  • Slovenia / English
  • South Africa / English
  • South Korea / 한국어
  • Spain / Español
  • Sweden / Svenska
  • Switzerland / English
  • Switzerland / Deutsch
  • Taiwan / English
  • Tanzania / English
  • Thailand / English
  • Tunisia / Français
  • Türkiye / Türkçe
  • UAE / English
  • Uganda / English
  • Ukraine / Українська мова
  • Ukraine / English
  • United Kingdom / English
  • United States / English
  • Venezuela / Español
  • Vietnam / English
  • Zambia / English
  • News & Events
    • All
    • News & Polls
    • Events
    • Webinars
    • Newsletter
  • Innovation & Knowledge
    • All
    • Media & Brand Communication
    • Consumer & Shopper
    • Customer Experience
    • Society
    • New Services
  • Our Solutions
    • All
  • Ipsos.digital platform
  • ESG
  • About us
    • Our history
    • Who we are
    • Key figures
    • Management
    • Values
    • Taking responsibility
    • The Path to Insights
    • Privacy & Data Collection
    • Online Data Quality Matters
    • Ipsos in the world
    • Media Resources
    • ISO Certification
  • Investors
  • Careers
    • Why Work at Ipsos
    • Opportunities at Ipsos
    • Professionals
    • Early Careers
    • Search Current Opportunities
    • The Path to Insights
  • Contact Us
  • Ipsos
  • Search

Search

Sort by Date Relevance
We found 129 results matching with your query. Refine by
  • Consumer & Shopper

    How GLP-1s create opportunities for brands and retailers to address new self-care needs

    CPG companies and retailers can act as trusted advisors and provide valuable advice and information, such as diet plans, exercise regimens, and ways to manage medication side effects. Here’s where to start.

    8 November 2024
  • Consumer & Shopper

    Reshaping Society: Insights to Activate

    GLP-1s have the potential to make a massive impact on the global economy. Stakeholders in various industries must adapt, and proactively, to stay ahead of the curve. Here’s how.

    28 October 2024
  • Consumer & Shopper

    GLP–1s: A Healthcare Revolution?

    One of this century’s biggest game-changers will likely be a novel drug class that’s showing unprecedented success, or the promise of it, in treating some of the world’s most prevalent conditions.

    28 October 2024
  • Consumer & Shopper

    Predicting Opportunity in Emerging Therapies

    We offer guidance for navigating these complex markets, emphasizing the need for robust primary market research, expert consultation, and a deep understanding of stakeholder perceptions.

    2 October 2024
  • Consumer & Shopper

    Bringing Healthcare Segmentations to Life With GenAI-Powered Persona

    Persona bots, fueled by sophisticated algorithms and trained on robust datasets, embody the attitudes, behaviors, and preferences of real-world doctors, patients, and pharmacists.

    14 August 2024
  • Consumer & Shopper

    Can we rely on generative AI for healthcare information?

    As generative AI continues to shape the patient experience, understanding how to best incorporate AI into the patient experience is crucial for healthcare organizations aiming to deliver an effective and preferred patient experience.

    29 July 2024
  • Consumer & Shopper

    Brand Success in the GLP-1 Era

    Our roadmap for GLP-1 brand success is based on the three fundamental pillars of understanding Context, acting with Empathy, and shaping Expectations.

    2 July 2024
  • Consumer & Shopper

    A Dose of Digital: Can Pharma Make DTx a Healthy Business?

    Digital therapeutics (DTx) are emerging as a potential game-changer in healthcare, offering evidence-based digital interventions to help prevent, manage, or treat specific conditions.

    7 June 2024
  • Consumer & Shopper

    What the Future: Wellness

    Watch our foresight webinar as we explore the future of wellness and how businesses across industries can support consumers with their goals.

    9 April 2024
  • Consumer & Shopper

    Navigating the Health Plan Partnership Labyrinth

    By understanding health plan imperatives, digital health companies can strategically position themselves for mutually beneficial collaborations and unlock significant commercial opportunities.

    10 March 2024
Pagination
  • Previous page <
  • Current page 2
  • Next page >
  • Page 10 10
  • Last page 13

Refine by

REFINE YOUR SEARCH FOR KEY WORD

  • (-) Innovation & Knowledge
    • (-) Consumer & Shopper
    • Customer Experience
    • Media & Brand Communication
    • New Services
    • Society
  • Citizens
  • Consumers & Brands
  • Capabilities
  • Doctors & Patients
  • Customers & Employees
  • About us
  • Contact Us
  • Press
  • Investors
  • Careers
© 2016 - 2025 Ipsos All Rights Reserved
  • Legal Mentions
  • Privacy & Data Protection
  • Cookie Policy
  • Our Alert System